Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
07/2000
07/04/2000US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto
07/04/2000US6083916 Pharmaceutical product for application to uterus mucosa
07/04/2000US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein
07/04/2000US6083483 For the modulation of the motility and peristalsis of the hollow organs of the urogenital and gastrointestinal tract
07/04/2000CA2116565C Low speed model following velocity command system for rotary wing aircraft
07/04/2000CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same
07/04/2000CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents
06/2000
06/29/2000WO2000037944A1 Kidney disease detection and treatment
06/29/2000WO2000037487A1 αvβ6 INTEGRIN INHIBITORS
06/29/2000WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/29/2000WO2000037450A1 NEW β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
06/29/2000WO2000037436A1 Sulfonamide hydroxamates
06/29/2000WO2000037422A2 Ion channel modulating agents
06/29/2000WO2000037358A1 NOVEL sPLA2 INHIBITORS
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000037085A1 Treatment of diseases involving cyst formation
06/29/2000WO2000037026A1 Dihydropyrimidines and uses thereof
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000002543A3 Antihypersensitive combination of valsartan and calcium channel blocker
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2356174A1 Kidney disease detection and treatment
06/29/2000CA2356159A1 Novel spla2 inhibitors
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/29/2000CA2355848A1 Dihydropyrimidines and uses thereof
06/29/2000CA2355251A1 New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
06/29/2000CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/28/2000EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same
06/28/2000EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit
06/28/2000EP1013275A2 Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
06/28/2000EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1011695A1 Use of neurotoxin therapy for treatment of urologic and related disorders
06/28/2000EP1011667A1 Antagonists of gonadotropin releasing hormone
06/28/2000EP1011648A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
06/28/2000EP0808318B1 Tricyclic substituted hexahydrobenz[e]isoindole alpha-1 adrenergic antagonists
06/28/2000CN1257736A Chinese medicine for curing nephritis
06/28/2000CN1257723A Medicine for dissolving and discharging calculi by omphalotherapy
06/28/2000CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them
06/28/2000CN1053886C Naphthyl compounds, intermediates and their preparing method and use
06/27/2000US6080774 Substituted biphenylsulfonamide endothelin antagonists
06/27/2000US6080769 Imidazolidin-4-one derivatives useful as anticancer agents
06/27/2000US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
06/27/2000US6080764 Superoxide radical inhibitor
06/27/2000US6080761 Inhibition of smooth muscle cell migration by (R)-amlodipine
06/27/2000US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders
06/27/2000CA2198564C Method of reducing tissue damage associated with non-cardiac ischemia
06/22/2000WO2000036105A1 Prostacyclin-stimulating factor-2
06/22/2000WO2000036103A1 Cytokine receptor chain
06/22/2000WO2000035939A2 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035936A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000WO2000035891A1 Morpholinone and morpholine derivatives and uses thereof
06/22/2000WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
06/22/2000WO2000035465A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
06/22/2000WO2000035444A1 USE OF η-TOCOPHEROL AND ITS OXIDATIVE METABOLITE LLU-α IN THE TREATMENT OF DISEASE
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000012504A3 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
06/22/2000WO2000007624A3 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355363A1 Prostacyclin-stimulating factor-2
06/22/2000CA2355249A1 Protease inhibitors
06/22/2000CA2355201A1 Morpholinone and morpholine derivatives and uses thereof
06/22/2000CA2354456A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2354422A1 Connective tissue growth factor fragments and methods and uses thereof
06/22/2000CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1009753A1 Hypoxia-regulated genes
06/21/2000EP1009743A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
06/21/2000EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
06/21/2000EP1009428A1 Vaginal suppository vaccine for urogenital infections
06/21/2000EP1009420A1 Conjugates useful in the treatment of prostate cancer
06/21/2000DE19858779A1 New 3-acylamino-propionic acid and 3-sulfonylamino-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiovascular and renal disorders, migraine and cancer
06/21/2000DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors
06/21/2000CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases
06/21/2000CN1257500A 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257474A New nitromethyl ketones, process for preparing them and compositions containing them
06/21/2000CN1256919A Shuanggan injection and preparation process thereof
06/21/2000CN1053672C Azasteroid compounds for treating prostatic hypertrophy, their preparation and use
06/21/2000CN1053585C Medicine for treating prostate diseases
06/20/2000US6077873 Steroid compounds having contraceptive and anti-osteoporosis activity
06/20/2000CA2198536C Method of reducing tissue damage associated with ischemia
06/20/2000CA2198535C Method of increasing testosterone
06/20/2000CA2001618C Gestodene-containing agent for transdermal administration
06/20/2000CA1341029C Peptidase inhibitors
06/15/2000WO2000034332A1 Glp-1 analogues
06/15/2000WO2000034331A2 Analogues of glp-1
06/15/2000WO2000034313A1 Procollagen c-proteinase inhibitors
06/15/2000WO2000034285A2 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
06/15/2000WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000WO2000034246A1 Crystalline form of an octahydro-benzo(f)quinolin-3-one derivative
06/15/2000WO2000034245A2 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase
06/15/2000WO2000034243A1 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
06/15/2000WO2000034230A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction
06/15/2000WO2000034228A1 Ion channel modulating agents
06/15/2000WO2000033869A2 Use of human prostrate cell lines in cancer treatment
06/15/2000WO2000033865A1 Methods of inhibiting ectopic calcification
06/15/2000WO2000033834A1 Use of isatin derivatives as ion channel activating agents
06/15/2000WO2000033828A1 Agent for lowering endothelin levels
1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 562